Detalhe da pesquisa
1.
Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof-of-Principle Issues from a Randomized Controlled Study.
Mov Disord
; 37(7): 1516-1525, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35607776
2.
Weight loss is correlated with disease severity in Spinocerebellar ataxia type 2: a cross-sectional cohort study.
Nutr Neurosci
; 25(8): 1747-1755, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33687306
3.
Testosterone Levels Are Decreased and Associated with Disease Duration in Male Spinocerebellar Ataxia Type 2 Patients.
Cerebellum
; 19(4): 597-604, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32440846